MLMi Hee Lim

Mi Hee Lim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mi Hee Lim has a total of 430 co-authors. Here are the top co-authors by number of shared publications:

  • Hyuck Jin Lee

    Department of Chemistry Education, Kongju National University, Gongju-si 32588, Chungcheongnam-do, Republic of Korea

    27 shared publications
  • Mingeun Kim

    Department of Chemistry Korea Advanced Institute of Science and Technology (KAIST) Daejeon Republic of Korea

    23 shared publications
  • Juhye Kang

    Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea

    21 shared publications
  • Eunju Nam

    Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea

    18 shared publications
  • Geewoo Nam

    Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea

    17 shared publications
  • Jiyeon Han

    Department of Chemistry Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Republic of Korea

    16 shared publications

Latest Publications

  • Open Access

    O2-Coupled Copper–Cysteine Redox Chemistry Drives Oxidative Modifications and Higher-Order Assembly of Monomeric Transthyretin

    by Yelim Yi, Wooyeol Ryu, Bokyung Kim, Srinivasan Muniyappan, Jin Hae Kim, Kiyoung Park, Mi Hee Lim

    Copper–cysteine (Cu–Cys) coordination is pervasive in biology, yet how Cu–thiol redox chemistry engages O2 and translates into protein-level consequences remains incompletely understood. Here, we establish a generalizable protein-based platform that directly captures O2-coupled Cu(II)–Cys redox processes and delineates their structural and functional outcomes. Integrated spectroscopic, mass spectrometric, and computational investigations reveal that Cu(II) coordination to a protein Cys residue initiates redox cycling that generates thiyl radicals and/or disulfide radical anions. This chemically defined process drives disulfide bond formation together with O2-dependent oxidative transformations, producing site-specific Cys modifications, dityrosine cross-links, and higher-order protein assemblies. Under these conditions, these structural changes abolish the protein’s anti-amyloidogenic activity and result in apoptotic responses. By directly linking Cu–thiol redox chemistry to protein oxidation and aggregation, this work establishes a fundamental chemical principle by which redox-active metal ions govern protein fate under aerobic conditions. More broadly, these findings provide a mechanistic framework for understanding how metal-mediated oxidative chemistry contributes to protein misfolding and aggregation in human diseases.

  • Open Access

    Zinc Fingers as Programmable Metalloprotein Scaffolds for Altering Pathogenic Biomolecular Phase Transitions

    by Seongmin Park, Yunha Hwang, Jimin Kwak, Yuxi Lin, Hye‐Yeon Park, Eunju Nam, Jiyeon Han, Soyeon Park, Hyunyong Kim, Ju‐Eun Kim, et al.

    Tunable control over biomolecular phase transitions provides a powerful blueprint for engineering functional soft materials, yet generalizable protein scaffolds capable of rewiring pathological condensates remain largely unexplored. Here, we demonstrate that zinc finger (ZF) proteins function as programmable interaction units that modulate neurodegenerative amyloid liquid–liquid phase separation, redirect β‐sheet‐rich fibrillation toward nontoxic assemblies, and actively disassemble preformed fibrils. Multiscale investigations spanning molecular, cellular, and organismal levels reveal that tandemly arrayed ZF modules mediate direct, high‐affinity protein–protein interactions, thereby mitigating amyloid pathogenicity. Through modular protein engineering, these protective effects translate in vivo, where a brain‐penetrant ZF variant reduces amyloid deposition, suppresses neuroinflammatory responses, and improves cognitive performance in Alzheimer's disease transgenic mice. Furthermore, sequence–structure–function analyses identify key determinants governing amyloid assembly control, offering mechanistic principles for ZF‐inspired protein engineering. Collectively, this work positions ZF proteins as versatile, chemically programmable platforms for engineering protein‐based materials that regulate biomolecular phase behavior and toxicity, expanding their functional scope beyond traditional genetic regulation toward therapeutic applications.

  • Open Access

    A glitazone-based chemical platform for mechanistic modulation of amyloid-β aggregation and associated pathology

    by Eunseo Hong, Seongmin Park, Yuxi Lin, Jimin Kwak, Young-Ho Lee, Mi Hee Lim

  • Reactivities of endocannabinoids toward metal-induced amyloid-β aggregation and oxidative stress associated with Alzheimer's disease

    by Byeongha Ahn, Jimin Lee, Seongmin Park, Mingeun Kim, Mi Hee Lim

    Endocannabinoids with metal-binding sites and amphiphilic properties alter metal–Aβ aggregation and control Cu( i / ii )- or Cu( i / ii )–Aβ-mediated ROS formation in a structure-dependent manner.

  • Metal Ions and Protein Aggregation: Unraveling Molecular Interactions and Theranostic Prospects in Proteinopathies

    by Danilo Milardi, Jiyeon Han, Hyuck Jin Lee, Feng Ding, Yifat Miller, Peter Faller, Ashley I Bush, Peter J. Crouch, David I. Finkelstein, Kay L. Double, et al.

    Protein aggregation is a pathological process associated with several human diseases termed proteinopathies, including neurodegenerative and metabolic disorders such as Alzheimer’s disease, Parkinson’s disease, type II diabetes, amyotrophic lateral sclerosis, and Huntington’s disease. In these conditions, specific proteins misfold and accumulate into insoluble aggregates, disrupting normal cellular function and contributing to disease progression. Many studies have investigated the molecular mechanisms that underlie the aggregation pathways, the structure of aggregates, such as oligomeric intermediates and fibrils, and their cellular toxicity. Studies have also investigated the effects of cofactors like metals, lipids, other amyloid proteins, and small molecules. Recent research has increasingly emphasized the critical roles of metal ions such as copper (Cu), zinc (Zn), iron (Fe), and manganese (Mn) in amyloid aggregation and toxicity. Alterations in metal ion transport, binding, or redox activity have been linked to the onset and progression of several amyloid-associated diseases. These metal ions can interact directly with amyloidogenic proteins, influencing their structural conformation, aggregation kinetics, and propensity to form toxic oligomers. This review aims to advance our understanding of how the regulation of metal ions within cells and their dysfunction contribute to the accumulation of harmful proteins, which is a key factor in proteinopathies. By examining the interactions between metal ions and key amyloidogenic proteins─including amyloid-β (Aβ), α-synuclein, tau, superoxide dismutase 1 (SOD1), human islet amyloid polypeptide (hIAPP), and insulin─we highlight both common and unique pathways through which metal ions influence protein aggregation. Additionally, this review explores the impact of metal ions on protein clearance mechanisms, such as autophagy and the ubiquitin–proteasome system, as well as emerging theranostic strategies. These include metal chelation therapies, metal-based imaging agents, and multifunctional compounds designed to restore metal balance while preventing aggregation and toxicity. By integrating biochemical, cellular, and therapeutic insights, this review contributes to a deeper understanding of the metallobiology of proteinopathies and supports the development of novel diagnostic and treatment approaches targeting metal–protein interactions.

  • Open Access

    Metal–organic macrocycles as molecular modulators of amyloid-β aggregation and cytotoxicity

    by Chanju Na, Gajendra Gupta, Mingeun Kim, Yena Choe, Junseong Lee, Chang Yeon Lee, Mi Hee Lim

    Rationally designed metal–organic macrocycles modulate amyloid-β aggregation through dual mechanisms involving direct peptide interactions and photoinduced oxidative modifications, resulting in reduced fibrillization and cytotoxicity.

  • Open Access

    Strategic physicochemical tuning: amphiphilic polymers as molecular regulators of amyloid aggregation and cytotoxicity

    by Jimin Kwak, Seongmin Park, Youngjin Kim, Yunha Hwang, Seung Jae Lee, Jeung Gon Kim, Mi Hee Lim

    Amyloidogenesis is a central pathological process in neurodegenerative disorders, yet general chemical principles that enable its predictive control are still insufficiently understood. Synthetic polymers offer a versatile and chemically tunable platform for modulating amyloid assembly; however, quantitative relationships linking polymer physicochemical properties to amyloidogenic pathways and biological outcomes remain poorly established. Here we present a systematic and quantitative framework that connects polymer composition to amyloid reactivity. By precisely tuning hydrophobicity, hydrophilicity, and net charge, and integrating polymer synthesis with computational, biochemical, and cellular analyses, we uncover clear structure–activity relationships governing interactions with amyloidogenic peptides and proteins, such as amyloid-β and α-synuclein. We show that balanced amphiphilic architectures, particularly hydrophobic–zwitterionic compositions, suppress fibrillization, redirect aggregation pathways, and reduce cellular membrane association, thereby attenuating cytotoxicity. In contrast, cationic-rich polymers promote aggregation via electrostatically driven mechanisms, while hydrophobic-dominant polymers exhibit minimal regulatory effects. Importantly, these composition-dependent behaviors are conserved across distinct amyloid systems, establishing a generalizable physicochemical framework in which the interplay between amphiphilicity and charge dictates amyloid reactivity and cellular responses. Overall, this work provides design principles for polymer-based chemical modulators and a broadly applicable strategy for controlling protein aggregation in neurodegenerative disease contexts.

  • Open Access

    A Prodrug Approach for Activity‐Based Chemical Modulation toward Multiple Pathological Targets in Alzheimer's Disease

    by Jimin Lee, Eunseo Hong, Chanju Na, Yan Li, Jun Go, Ju‐Eun Kim, Hyun‐Hee Seo, Jong‐Min Suh, Jimin Kwak, Young‐Ho Lee, et al.

    Targeting disease‐specific chemical signals enables precise therapeutic control over complex pathologies. In Alzheimer's disease (AD), elevated hydrogen peroxide (H 2 O 2 ) accompanies hallmark features, including amyloid‐β (Aβ) aggregate deposition and metal ion dyshomeostasis, creating an oxidative milieu primed for selective chemical activation. Here, we show a rationally designed prodrug platform that harnesses H 2 O 2 as an endogenous trigger for redox‐based therapy. Boronic ester‐masked precursors ( BE‐1 and BE‐2 ) remain inert under physiological conditions but undergo rapid oxidative deboronation in the presence of H 2 O 2 , releasing redox‐active aminophenols. These activated molecules exhibit multimodal pathological modulation, as revealed by molecular‐level biochemical and biophysical analyses: scavenging reactive oxygen species, inducing residue‐specific oxidative modifications of Aβ, and redirecting aggregation pathways of both metal‐free and metal‐bound Aβ. In AD transgenic mice, BE‐1 undergoes conversion to its active form within the brain tissue. Long‐term administration of BE‐1 markedly reduces hippocampal oxidative stress, lowers amyloid plaque burden, and improves cognitive performance. This pathology‐responsive, activity‐based prodrug strategy provides a chemically precise framework for simultaneously modulating multiple, interconnected drivers of neurodegeneration.

  • Chemical Strategies to Modulate Amyloidogenesis Associated with Neurodegenerative Diseases

    by Chanju Na, Youngeun Jang, Mikyung Son, Mi Hee Lim

    Amyloidogenic peptides and proteins, including amyloid-β, tau, and α-synuclein, are key pathological factors in neurodegenerative diseases. Their misfolding and self-assembly into toxic oligomers and fibrils disrupt cellular homeostasis and lead to neuronal dysfunction. To address these pathogenic processes, diverse chemical strategies have been developed employing nanomaterials, small organic molecules, and metal complexes. These reagents chemically modify amyloidogenic peptides and proteins, thereby altering their aggregation pathways, attenuating associated toxicity, and demonstrating in vivo efficacy. In this review, we outline and discuss the design principles and mechanistic bases of these chemical interventions, with some examples that demonstrate anti-amyloidogenic effects. Collectively, these advances underscore the power of chemistry to modulate amyloid aggregation and provide mechanistic insights that can guide the development of innovative therapeutic strategies for amyloid-driven neurodegeneration.